4.5 Article

Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis

Journal

JOURNAL OF LEUKOCYTE BIOLOGY
Volume 88, Issue 2, Pages 313-319

Publisher

WILEY
DOI: 10.1189/jlb.0110049

Keywords

Rap1; adhesion; F-actin; polarization

Funding

  1. National Heart, Lung and Blood Institute of the National Institutes of Health [P01 HL056949, P01 HL066105]
  2. DFG [GO1360/4-1]
  3. IMF Munster
  4. NIH [HL085100, AI076471, HL092020, GM076084]
  5. American Cancer Society

Ask authors/readers for more resources

Chemotaxis and integrin activation are essential processes for neutrophil transmigration in response to injury. CalDAG-GEFI plays a key role in the activation of beta 1, beta 2, and beta 3 integrins in platelets and neutrophils by exchanging a GDP for a GTP on Rap1. Here, we explored the role of CalDAG-GEFI and Rap1b in integrin-independent neutrophil chemotaxis. In a transwell assay, CalDAG-GEFI(-/-) neutrophils had a 46% reduction in transmigration compared with WT in response to a low concentration of LTB4. Visualization of migrating neutrophils in the presence of 10 mM EDTA revealed that CalDAG-GEFI(-/-) neutrophils had abnormal chemotactic behavior compared with WT neutrophils, including reduced speed and directionality. Interestingly, Rap1b(-/-) neutrophils had a similar phenotype in this assay, suggesting that CalDAG-GEFI may be acting through Rap1b. We investigated whether the deficit in integrin-independent chemotaxis in CalDAG-GEFI(-/-) neutrophils could be explained by defective cytoskeleton rearrangement. Indeed, we found that CalDAG-GEFI(-/-) neutrophils had reduced formation of F-actin pseudopodia after LTB4 stimulation, suggesting that they have a defect in polarization. Overall, our studies show that CalDAG-GEFI helps regulate neutrophil chemotaxis, independent of its established role in integrin activation, through a mechanism that involves actin cytoskeleton and cellular polarization. J. Leukoc. Biol. 88: 313-319; 2010.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Peripheral serotonin lacks effects on endothelial adhesion molecule expression in acute inflammation

Maximilian Mauler, Nancy Schanze, Krystin Krauel, Claudia Schoenichen, Franziska Glatzki, Susanna Poeschl, Daniela Stallmann, Julius Mezger, Nadine Gauchel, Diana Sharipova, Marina Rieder, Ingo Hilgendorf, Thilo Witsch, Christoph Bode, Daniel Duerschmied

Summary: Peripheral serotonin seems to have no effect on endothelial adhesion molecule expression, despite its influence on neutrophil function. The inflammatory release of peripheral serotonin appears to be unnecessary for regulating endothelial adhesion molecules.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Cardiac & Cardiovascular Systems

Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease

Nadine Gauchel, Marina Rieder, Krystin Krauel, Isabella Goller, Maren Jeserich, Ulrich Salzer, Ana Cecilia Venhoff, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, Winfried Kern, Siegbert Rieg, Hans-Jorg Busch, Maike Hofmann, Christoph Bode, Daniel Duerschmied, Achim Lother, Lukas A. Heger

Summary: This study compared the levels of complement system components in COVID-19 patients and other groups, revealing that COVID-19 patients had significantly elevated levels of CS components 5a and 4, increased levels of vWF antigen, and a significant correlation with vWF antigen, suggesting a pronounced immune inflammatory response in COVID-19 disease.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Article Cardiac & Cardiovascular Systems

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, Udaya S. Tantry, Jeffrey S. Berger, Mark Y. Chan, Daniel Duerschmied, Susan S. Smyth, William A. E. Parker, Ramzi A. Ajjan, Gemma Vilahur, Lina Badimon, Jurrien M. ten Berg, Hugo ten Cate, Flora Peyvandi, Taia T. Wang, Richard C. Becker

Summary: COVID-19 predisposes patients to thrombotic and thromboembolic events. Numerous biomarkers have emerged to assess the thrombotic risk in these patients, informing prognosis and predicting thrombosis.

NATURE REVIEWS CARDIOLOGY (2022)

Article Critical Care Medicine

Cytokine adsorption in patients with post-cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER) - A single-centre, open-label, randomised, controlled trial

Alexander Supady, Timm Zahn, Moritz Kuhl, Sven Maier, Christoph Benk, Klaus Kaier, Bernd W. Boettiger, Christoph Bode, Achim Lother, Dawid L. Staudacher, Tobias Wengenmayer, Daniel Duerschmied

Summary: Cytokine adsorption did not reduce serum IL-6 levels and had no significant effect on survival, vasopressor support, or biomarkers of injury in patients receiving ECPR.

RESUSCITATION (2022)

Review Hematology

Platelets in Myocardial Ischemia/Reperfusion Injury

Nancy Schanze, Muataz Ali Hamad, Thomas Georg Nuehrenberg, Christoph Bode, Daniel Duerschmied

Summary: Coronary artery disease is a leading cause of global mortality, with ischemia/reperfusion injury (IRI) contributing to cardiac damage. Platelets play an important role in IRI through activation and interaction with other cells. Understanding platelet contributions to IRI is crucial for developing effective treatment strategies.

HAMOSTASEOLOGIE (2023)

Article Hematology

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Andre Frenk, Bernhard Gerber, Andrea Goetschi, Stavros Konstantinides, Francois Mach, Helia Robert-Ebadi, Thomas Rosemann, Noemi R. Simon, Herve Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher

Summary: This study aimed to investigate whether thromboprophylaxis with enoxaparin would prevent hospitalization and death in symptomatic COVID-19 outpatients. The results showed that enoxaparin did not reduce the risk of hospitalization and death among these patients.

LANCET HAEMATOLOGY (2022)

Article Medicine, General & Internal

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Diona Gjermeni, Hannah Vetter, Sofia Szabo, Viktoria Anfang, Stefan Leggewie, David Hesselbarth, Daniel Duerschmied, Dietmar Trenk, Christoph B. Olivier

Summary: This study compared the performance of multiple platelet aggregometry (MEA) and thrombelastography (TEG) in detecting high on-clopidogrel platelet reactivity (HPR) in patients with atrial fibrillation (AF) and indication for oral anticoagulation (OAC) after percutaneous coronary intervention (PCI). The results showed that TEG detected higher rates of HPR compared to MEA. Conventional cut-off values for HPR may need to be re-evaluated for this high-risk population. Further studies are needed to assess the association with outcomes.

JOURNAL OF CLINICAL MEDICINE (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Association of Cytochrome P450 2C19 polymorphisms with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention

Diona Gjermeni, Sofia Szabo, Viktoria Anfang, Hannah Theresa Vetter, Carina Juelch, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Daniel Duerschmied, Christoph B. Olivier

CARDIOVASCULAR RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study

Christian Fastner, Goekhan Yuecel, Svetlana Hetjens, Boris Rudic, Gereon Schmiel, Matthias Toepel, Volker Liebe, Mathieu Kruska, Martin Borggrefe, Daniel Burkhoff, Ibrahim Akin, Daniel Duerschmied, Juergen Kuschyk

Summary: This study compared the effects of CCM treatment over 5 years in patients with baseline NYHA class II vs. III/IV, finding that patients with NYHA III/IV showed more significant improvements in functional parameters and survival benefits.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Peripheral Vascular Disease

Endothelial Rap1B mediates T-cell exclusion to promote tumor growth: a novel mechanism underlying vascular immunosuppression

Guru Prasad Sharma, Ramoji Kosuru, Sribalaji Lakshmikanthan, Shikan Zheng, Yao Chen, Robert Burns, Gang Xin, Weiguo Cui, Magdalena Chrzanowska

Summary: This study identifies the role of Rap1B in tumor growth and immunosuppression. Rap1B deficiency restricts tumor growth and enhances the activity of CD8(+) T-cells, improving the efficacy of immunotherapy.

ANGIOGENESIS (2023)

Article Cardiac & Cardiovascular Systems

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

Anna C. Mavromanoli, Stefano Barco, Walter Ageno, Helene Bouvaist, Marianne Brodmann, Claudio Cuccia, Francis Couturaud, Claudia Dellas, Konstantinos Dimopoulos, Daniel Duerschmied, Klaus Empen, Pompilio Faggiano, Emile Ferrari, Nazzareno Galie, Marcello Galvani, Alexandre Ghuysen, George Giannakoulas, Menno Huisman, David Jimenez, Matija Kozak, Irene M. Lang, Nicolas Meneveau, Thomas Muenzel, Massimiliano Palazzini, Antoniu Octavian Petris, Giancarlo Piovaccari, Aldo Salvi, Sebastian Schellong, Kai-Helge Schmidt, Franck Verschuren, Irene Schmidtmann, Gerrit Toenges, Frederikus A. Klok, Stavros Konstantinides

Summary: This study analyzed the changes in RV function in patients with intermediate-risk PE who were switched early to oral anticoagulation. The results showed that the majority of patients had normalized RV function within 6 days and maintained normal RV function throughout the first 6 months. However, almost one in four patients continued to have evidence of RV dysfunction over the long term.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Article Hematology

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

Davide Voci, Andrea Gotschi, Ulrike Held, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Riccardo M. Fumagalli, Bernhard Gerber, Barbara Hasse, Dagmar I. Keller, Stavros V. Konstantinides, Francois Mach, Silvana K. Rampini, Marc Righini, Helia Robert-Ebadi, Thomas Rosemann, Stephanie Roth-Zetzsche, Tim Sebastian, Noemi R. Simon, David Spirk, Stefan Stortecky, Lukas Vaisnora, Nils Kucher, Stefano Barco

Summary: The benefits of early thromboprophylaxis in symptomatic COVID-19 outpatients remain unclear. This study presents the 90-day results from the OVID phase III trial, which showed that early thromboprophylaxis with enoxaparin did not improve the course of COVID-19 in terms of hospitalization, death, or resolution of symptoms.

THROMBOSIS RESEARCH (2023)

Review Virology

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment

Aydin Huseynov, Ibrahim Akin, Daniel Duerschmied, Ruediger E. Scharf

Summary: An increasing number of post-COVID patients are experiencing long-term complications from the acute COVID-19 infection, posing ongoing challenges for healthcare professionals. It has become clear that COVID-19 not only affects the respiratory system but also other organs, including the cardiovascular system. Cardiopulmonary symptoms such as shortness of breath, palpitations, limited physical capacity, and cardiac arrhythmias can persist in a significant proportion of recovered patients. This article reviews the prevalence and underlying mechanisms of COVID-19-associated arrhythmias and discusses the clinical management of various rhythm disorders in post-COVID patients.

VIRUSES-BASEL (2023)

Article Biology

B cell receptor-induced IL-10 production from neonatal mouse CD19+CD43- cells depends on STAT5-mediated IL-6 secretion

Jiro Sakai, Jiyeon Yang, Chao-Kai Chou, Wells W. Wu, Mustafa Akkoyunlu

Summary: Newborns have a lower humoral immune response than adults due to the immunoregulatory role of IL-10. This study found that both B-1 cells and non-B-1 cells in neonatal mice produce IL-10 in response to B cell antigen receptor (BCR) activation. The production of IL-10 is mediated by the activation of STAT5 and IL-6, and further activates STAT3. IL-10 secreted by neonatal non-B-1 cells can inhibit TNF-alpha secretion by macrophages.

ELIFE (2023)

Article Hematology

Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function

Marina Rieder, Niklas Baldus, Daniela Stallmann, Maren Jeserich, Isabella Goller, Luisa Wirth, Luisa Pollmeier, Maike Hofmann, Christoph Bode, Hans-Joerg Busch, Bonaventura Schmid, Nadine Gauchel, Rudiger E. Scharf, Daniel Duerschmied, Achim Lother, Krystin Krauel

Summary: This study aimed to assess platelet reactivity in patients with moderate COVID-19 at early stages. Platelet reactivity was evaluated using whole-blood impedance aggregometry and flow cytometry in 20 COVID-19-positive patients, 55 COVID-19-negative patients (as patient controls), and 15 healthy individuals.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

No Data Available